Finward Bancorp
BMY icon

Finward Bancorp’s Bristol-Myers Squibb BMY Stock Holding History

Finward Bancorp’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$225K Sell
3,605
-90
-2% -$5.69K 0.17% 97
2026
Q2 		$213K Hold
3,695
– – 0.16% 103
2026
Q1 		$224K Buy
+3,695
New +$215K 0.18% 98
2025
Q2 		– Sell
-3,695
Closed -$225K – 102
2025
Q1 		$225K Sell
3,695
-169
-4% -$9.9K 0.2% 94
2024
Q4 		$219K Buy
+3,864
New +$216K 0.19% 93

Other funds holding BMY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Artemis Investment Management
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
Fort Washington Investment Advisors
Fort Washington Investment Advisors Cincinnati, Ohio $19.7B AUM 20.11% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Douglas Lane & Associates
Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return
MN Services Vermogensbeheer
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
Czech National Bank
Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

Finward Bancorp's BMY Position: Q3 2026 in Review

Finward Bancorp reduced its Bristol-Myers Squibb (BMY) stake by 2.4% in Q3 2026, selling an estimated $5.69K and leaving 3,605 shares worth $225K. The position accounts for 0.17% of the portfolio, ranked #97.

Finward Bancorp first reported a position in BMY in Q4 2024 and has held it in 5 quarters since. The position peaked at $225K in Q1 2025. 623 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • Finward Bancorp held 3,605 shares of Bristol-Myers Squibb worth $225K as of Q3 2026.
  • Finward Bancorp sold 90 Bristol-Myers Squibb shares in Q3 2026, an estimated $5.69K.
  • Bristol-Myers Squibb made up 0.17% of Finward Bancorp's portfolio in Q3 2026, its #97 holding.
  • Finward Bancorp first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 5 quarters since.
  • Finward Bancorp's Bristol-Myers Squibb position peaked at $225K in Q1 2025.
  • 623 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Finward Bancorp's 13F filing for Q3 2026, filed 14 Oct 2026.